Tanat Vaniyapong

Prof. Tanat Vaniyapong

Chiang Mai University
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
WCWilaiwan Chongruksut
Wilaiwan Chongruksut
TVTanat Vaniyapong
Tanat Vaniyapong
KRKittipan Rerkasem
Kittipan Rerkasem

19 December 2013 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
TVTanat Vaniyapong
Tanat Vaniyapong
WCWilaiwan Chongruksut
Wilaiwan Chongruksut
KRKittipan Rerkasem
Kittipan Rerkasem

1 February 2017 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
JMJutaporn Maneewong
Jutaporn Maneewong
BMBenchalak Maneeton
Benchalak Maneeton
NMNarong Maneeton
Narong Maneeton
TVTanat Vaniyapong
Tanat Vaniyapong
PTPatrinee Traisathit
Patrinee Traisathit
MSManit Srisurapanont
Manit Srisurapanont
Background: Delirium in traumatic brain injury (TBI) is common, may be predictable, and has a multifaceted symptom complex. This study aimed to examine: 1) the sum score of Glasgow Coma Scale (GCS) and if its component scores could predict delirium in TBI patients, and 2) the prominent symptoms and their courses over the first days after TBI. Methods: TBI patients were recruited from neurosurgical ward inpatients. All participants were hospitalized within 24 hours after their TBI. Apart from the sum score of GCS, which was obtained at the emergency department (ED), the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, diagnostic criteria for delirium were applied daily. The severity of delirium symptoms was assessed daily using the Delirium Rating Scale – Revised-98 (DRS-R-98). Results: The participants were 54 TBI patients with a mean GCS score of 12.7 (standard deviation [SD] =2.9). A total of 25 patients (46.3%) met the diagnosis of delirium and had a mean age of 36.7 years (SD =14.8). Compared with 29 non-delirious patients, 25 delirious patients had a significantly lower mean GCS score (P=0.04), especially a significantly lower verbal component score (P=0.03). Among 18 delirious patients, four symptoms of the DRS-R-98 cognitive domain (orientation, attention, long-term memory, and visuospatial ability) were moderate symptoms (score ≥2) at the first day of admission. After follow-up, three cognitive (orientation, attention, and visuospatial ability) and two noncognitive symptoms (lability of affect and motor agitation) rapidly resolved. Conclusion: Almost half of patients with mild to moderate head injuries may develop delirium in the first 4 days after TBI. Those having a low GCS score, especially the verbal component score, at the ED were likely to have delirium in this period. Most cognitive domains of delirium described in the DRS-R-98 were prominent within the first 4 days of TBI with delirium. Three cognitive and two noncognitive symptoms of delirium decreased significantly.

1 January 2020 in Journal of Neurosciences in Rural Practice
Verified
Journal Article
Open access
PDF file
TTThara Tunthanathip
Thara Tunthanathip
SRSanguansin Ratanalert
Sanguansin Ratanalert
SSSakchai Sae-Heng
Sakchai Sae-Heng
TOThakul Oearsakul
Thakul Oearsakul
ISIttichai Sakaruncchai
Ittichai Sakaruncchai
TVTanat Vaniyapong
Tanat Vaniyapong
Background Prognosis of low-grade glioma are currently determined by genetic markers that are limited in some countries. This study aimed to use clinical parameters to develop a nomogram to predict survival of patients with diffuse astrocytoma (DA) which is the most common type of low-grade glioma. Materials and Methods Retrospective data of adult patients with DA from three university hospitals in Thailand were analyzed. Collected data included clinical characteristics, neuroimaging findings, treatment, and outcomes. Cox’s regression analyses were performed to determine associated factors. Significant associated factors from the Cox regression model were subsequently used to develop a nomogram for survival prediction. Performance of the nomogram was then tested for its accuracy. Results There were 64 patients with DA with a median age of 39.5 (interquartile range [IQR] = 20.2) years. Mean follow-up time of patients was 42 months (standard deviation [SD] = 34.3). After adjusted for three significant factors associated with survival were age ≥60 years (hazard ratio [HR] = 5.8; 95% confidence interval [CI]: 2.09–15.91), motor response score of Glasgow coma scale < 6 (HR = 75.5; 95% CI: 4.15–1,369.4), and biopsy (HR = 0.45; 95% CI: 0.21–0.92). To predict 1-year mortality, sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and area under the curve our nomogram was 1.0, 0.50, 0.45, 1.0, 0.64, and 0.75, respectively. Conclusions This study provided a nomogram predicting prognosis of DA. The nomogram showed an acceptable performance for predicting 1-year mortality.

1 October 2020 in Asian Journal of Surgery
Verified
Journal Article
Open access
WCWilaiwan Chongruksut
Wilaiwan Chongruksut
KLKriengsak Limpastan
Kriengsak Limpastan
CJChumpon Jetjumnong
Chumpon Jetjumnong
WWWanarak Watcharasaksilp
Wanarak Watcharasaksilp
TVTanat Vaniyapong
Tanat Vaniyapong
KRKittipan Rerkasem
Kittipan Rerkasem
The aim of the present study was to identify incidences and prognostic factors for 30-day mortality of hemorrhagic strokes (HS) and divide them into intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). This retrospective cohort study was conducted using medical records of patients who underwent surgery due to HS, between January 2013 and April 2017, at Chiang Mai University Hospital, a large tertiary referral center, in Northern Thailand. 30-day mortality was followed after surgery. Prognostic factors included patients' characteristics, and clinical date related to early death, were determined. Data analysis was performed using Cox's proportional hazards model. 460 patients were enrolled. The 30-day mortality rate was 8.8% and 12.3%, in ICH and SAH patients, respectively. Multivariable analyses demonstrated that the prognostic factors of early mortality in ICH patients were age 65-70 years (Adjusted HR 3.10 (95%CI 1.14-8.41)), >70 years (Adj.HR 2.64 (95%CI 1.09-6.36)) and hypertension (HT) (Adj.HR 2.98 (95%CI 1.25-7.12)). In SAH patients, prognostic factors were HT (Adj.HR 7.32 (95%CI 2.12-25.29)), and atrial fibrillation (AF) (Adj.HR 5.48 (95% CI 1.57-19.09)). Ages over 65 years and HT were an important predictor of 30-day mortality in a subgroup of ICH patients, whereas HT and AF were significant prognostic factors in SAH. To reduce early death, management for stroke cases needed to take into account the specifics for older age patients with HT, and AF.

2 April 2016 in Neurological Research
Verified
Journal Article
Closed access
DNDanop Nanegrungsunk
Danop Nanegrungsunk
NANattayaporn Apaijai
Nattayaporn Apaijai
CYChontida Yarana
Chontida Yarana
JSJirapas Sripetchwandee
Jirapas Sripetchwandee
KLKriengsak Limpastan
Kriengsak Limpastan
SCSiriporn C Chattipakorn
Siriporn C Chattipakorn
Objective: Current chemotherapy treatments available for treating high-grade brain tumors, Temozolomide (TMZ) or Bevacizumab (BEV), not only have specific anti-tumor mechanisms, but also have an effect on mitochondria. However, effects of both drugs on mitochondria isolated from human brain tumors have not been thoroughly investigated. This study determined the direct effects of TMZ and BEV as well as the neurotoxic condition (calcium overload), on the function of mitochondria and compared these effects on mitochondria isolated from low- and high-grade human brain tumors. Methods: Mitochondria were isolated from either low- or high-grade human primary brain tumors. Calcium overload conditions (100 or 200 μM), TMZ (300 μM), and BEV (2 mg/mL) were applied to isolated mitochondria from low- and high-grade brain tumors. Following the treatment, mitochondrial function, including reactive oxygen species production, membrane potential changes, and swelling, were determined. The mitochondrial morphology was also examined. Results: In calcium overload conditions, mitochondrial dysfunction was only found to have occurred in low-grade tumors. In TMZ and BEV treatment, BEV, rather than TMZ, caused greater membrane depolarization and mitochondrial swelling in both grades of brain tumors. Conclusions: TMZ and BEV can directly cause the dysfunction of mitochondria isolated from human brain tumors. However, BEV has a greater ability to disturb mitochondrial function in mitochondria isolated from human brain tumors than either TMZ or calcium overload conditions.